1. McNeilly JD, Boal R, Shaikh MG, Ahmed SF. Frequency and aetiology of hypercalcaemia. Arch Dis Child. 2016; 101:344–7.
Article
2. Stokes VJ, Nielsen MF, Hannan FM, Thakker RV. Hypercalcemic disorders in children. J B one Miner Res. 2017; 32:2157–70.
Article
3. Bilezikian JP. Primary hyperparathyroidism. J Clin Endocrinol Metabol. 2018; 103:3993–4004.
Article
4. Cormier C. Genetic hypercalcemia. Joint Bone Spine. 2019; 86:459–66.
Article
5. Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018; 14:115–25.
Article
6. Kollars J, Zarroug AE, van Heerden J, Lteif A, Stavlo P, Suarez L, et al. Primary hyperparathyroidism in pediatric patients. Pediatrics. 2005; 115:974–80.
Article
7. Nicholson KJ, McCoy KL, Witchel SF, Stang MT, Carty SE, Yip L. Comparative characteristics of primar y hyperparathyroidism in pediatric and young adult patients. Surgery. 2016; 160:1008–16.
Article
8. Roy M, Mazeh H, Chen H, Sippel RS. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg. 2013; 37:102–6.
Article
9. Li CC, Yang C, Wang S, Zhang J, Kong XR, Ouyang J. A 10-year retrospective study of primary hyperparathyroidism in children. Exp Clin Endocrinol Diabetes. 2012; 120:229–33.
Article
10. Liu X, Sun L, Shao M, Li P, Liu W, Zhang X, et al. Primary hyperparathyroidism due to ectopic parathyroid adenoma in an adolescent: a case report and review of the literature. Endocrine. 2019; 64:38–42.
11. Arambewela MH, Liyanarachchi KD, Somasundaram NP, Pallewatte AS, Punchihewa GL. Case report: rare skeletal manifestations in a child with primary hyperparathyroidism. BMC Endocr Disord. 2017; 17:45.
Article
12. Udelsman R, Akerstrom G, Biagini C, Duh QY, Miccoli P, Niederle B, et al. The surgical management of asymptomatic primar y hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab. 2014; 99:3595–606.
13. Khan AA, Hanley DA, Rizzoli R, Bollerslev J, Young JE, Rejnmark L, et al. Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus. Osteoporos Int. 2017; 28:1–19.
Article
14. Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012; 19:577–83.
Article
15. Iihara M, Suzuki R, Kawamata A, Horiuchi K, Okamoto T. Thoracoscopic removal of mediastinal parathyroid lesions: selection of surgical approach and pitfalls of preoperative and intraoperative localization. World J Surg. 2012; 36:1327–34.
Article
16. Kaplan EL, Yashiro T, Salti G. Primary hyperparathyroidism in the 1990s. Choice of surgical procedures for this disease. Ann Surg. 1992; 215:300–17.
17. Chou PL, Chao YK, Liu YH. Minimally invasive removal of mediastinal ectopic parathyroid glands: a single-center experience. Formos J Surg. 2019; 52:6–10.
18. Said SM, Cassivi SD, Allen MS, Deschamps C, Nichols FC 3rd, Shen KR, et al. Minimally invasive resection for mediastinal ectopic parathyroid glands. Ann Thorac Surg. 2013; 96:1229–33.
Article
19. Thakker RV, Newey PJ, Walls GV, Bilezikian J, Dralle H, Ebeling PR, et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metabol. 2012; 97:2990–3011.
Article